Published

The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Pharmacology, biochemistry, and behavior
Date: 2025-11-01
Source: PubMed
DOI: 10.1016/j.pbb.2025.174087
PubMed: 40849009

Authors

Rahmani S Crupi R Riley AL Davidson T

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD Mechanism of Action Safety Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelic Therapies in the Management of Post-Traumatic Stress DisorderJournal of Education Health and Sport · 2026-07-16 Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.Frontiers in neuroscience · 2026-01-01 Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimizationFrontiers in Psychiatry · 2025-04-08 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Should addiction researchers be interested in psychedelic science?Drug and Alcohol Review · 2017-04-10 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 Default Mode Network Modulation by Psychedelics: A Systematic Review.The international journal of neuropsychopharmacology · 2023-03-22 The combination of exercise and psychedelics for the treatment of major depressive disorder.Discover mental health · 2026-03-07